Home Markets AbbVie shares hit record high as key immunology drug set for exclusivity until 2037

AbbVie shares hit record high as key immunology drug set for exclusivity until 2037

Andrew M Sep 11, 2025 comments off

Original source: https://www.investing.com/news/stock-market-news/abbvie-shares-hit-record-high-as-key-immunology-drug-set-for-exclusivity-until-2037-4235812

ABBVIE Market Updates Pharmaceuticals (NEC) www.investing.com/news/stock-market-news/abbvie-shares-hit-record-high-as-key-immunology-drug-set-for-exclusivity-until-2037-4235812